Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Obesity Surgery, 2025

Changes in Inflammatory Markers Following Bariatric Surgery and the Impact of the Surgical Procedure: A 12-Month Longitudinal Study

Jensen R., Thuesen A., Huang Y. et al.

Scientific Reports, 2025

Plasma inflammation-related proteins associated with anxiety and depression disorders in IBD patients

Zhou M., Zhang W., Dang Y. et al.

Liver Cancer, 2025

Camrelizumab combined with Lenvatinib and RALOX-HAIC for unresectable hepatocellular carcinoma (Cal Era): a prospective, single-arm, phase II trial

Zang M., Li Q., Hu X. et al.

Nature Communications, 2025

Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk

Zalesky A., Tian Y., Ferrucci L. et al.

Thrombosis Journal, 2025

Therapeutic targets for venous thromboemblism: proteome-wide mendelian randomization and colocalization analyses

Li X., Yang C., Zhou M. et al.

Infection, 2025

Antigen-specific chemokine CCL3 as a biomarker for distinguishing between recent and remote tuberculosis infection

Chang C., Ma Z., Ren W. et al.

Journal of Inflammation Research, 2025

Using Olink Proteomics to Identify Inflammatory Biomarkers in the Cerebrospinal Fluid in Guillain-Barré Syndrome

Sun S., Li M., Song J. et al.

Molecular Oncology, 2025

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Gudoityte G., Sharma O., Leuenberger L. et al.

International Journal of Cardiology Cardiovascular Risk and Prevention, 2025

Circulating protein biomarkers and their association with vulnerable plaque characteristics – a PROSPECT II substudy

Sharma T., Maehara A., Maeng M. et al.

Journal of Cardiac Failure, 2025

The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring

de Jong M., Allach Y., Kamar S. et al.

Med, 2025

Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality

Le T., van Abeelen K., Ardiansyah E. et al.

Nature Communications, 2025

The health impacts and genetic architecture of food liking in cardio-metabolic diseases

Jiang W., Wang H., Geng Y. et al.

Signal Transduction and Targeted Therapy, 2025

Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study

Xie M., Bao M., Dong X. et al.

European Neuropsychopharmacology, 2025

Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis

Oliva V., Possidente C., Fanelli G. et al.

Nature Communications, 2025

FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma

Beffinger M., Schellhammer L., Taskoparan B. et al.

Circulation, 2025

Proteomic Signatures for Risk Prediction of Atrial Fibrillation

Park H., Norby F., Kim D. et al.

The American Journal of Clinical Nutrition, 2025

Relationship of healthy lifestyle with healthy aging and the mediation by plasma proteins: a prospective cohort study

Fang F., Liu Z., Lyu J. et al.

Medicine, 2025

Roles of plasma proteins in mediating the causal effect of the lipid species on gastric cancer: Insights from proteomic and two-step Mendelian randomization

Dong Z., Chen Z., Yu K. et al.

Journal of Interferon & Cytokine Research, 2025

Significant Associations Between Blood Cell Counts and a Large Number of Salivary Cytokines, Chemokines, and Growth Factors

Eriksson L., Eriksson M., Gordh T. et al.

Nature Communications, 2025

In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome

Mizumaki H., Gao S., Wu Z. et al.

4555 publications